IL154593A0 - 3-(heteroaryl acetamido)-2-oxoazetidine-1-sulfonic acid derivatives as antibacterial agents - Google Patents
3-(heteroaryl acetamido)-2-oxoazetidine-1-sulfonic acid derivatives as antibacterial agentsInfo
- Publication number
- IL154593A0 IL154593A0 IL15459301A IL15459301A IL154593A0 IL 154593 A0 IL154593 A0 IL 154593A0 IL 15459301 A IL15459301 A IL 15459301A IL 15459301 A IL15459301 A IL 15459301A IL 154593 A0 IL154593 A0 IL 154593A0
- Authority
- IL
- Israel
- Prior art keywords
- oxoazetidine
- sulfonic acid
- acid derivatives
- antibacterial agents
- acetamido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23261700P | 2000-09-14 | 2000-09-14 | |
| PCT/IB2001/002115 WO2002022613A1 (en) | 2000-09-14 | 2001-09-14 | 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL154593A0 true IL154593A0 (en) | 2003-09-17 |
Family
ID=22873854
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15459301A IL154593A0 (en) | 2000-09-14 | 2001-09-14 | 3-(heteroaryl acetamido)-2-oxoazetidine-1-sulfonic acid derivatives as antibacterial agents |
| IL154593A IL154593A (en) | 2000-09-14 | 2003-02-24 | History of Acids 3 - (Traueril Acetamido) - 2 - Oxo - Aztidine - 1 Sulphanes as Antibacterial Factors |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL154593A IL154593A (en) | 2000-09-14 | 2003-02-24 | History of Acids 3 - (Traueril Acetamido) - 2 - Oxo - Aztidine - 1 Sulphanes as Antibacterial Factors |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6916803B2 (pt) |
| EP (1) | EP1322648B1 (pt) |
| JP (1) | JP2004509122A (pt) |
| KR (1) | KR100854810B1 (pt) |
| CN (1) | CN1189469C (pt) |
| AT (1) | ATE298750T1 (pt) |
| AU (2) | AU1261402A (pt) |
| BR (1) | BR0113861A (pt) |
| CA (1) | CA2422375C (pt) |
| CZ (1) | CZ304586B6 (pt) |
| DE (1) | DE60111757T2 (pt) |
| DK (1) | DK1322648T3 (pt) |
| ES (1) | ES2244666T3 (pt) |
| HK (1) | HK1054377A1 (pt) |
| HU (1) | HUP0301025A3 (pt) |
| IL (2) | IL154593A0 (pt) |
| NO (1) | NO324946B1 (pt) |
| NZ (1) | NZ524292A (pt) |
| PL (1) | PL218196B1 (pt) |
| PT (1) | PT1322648E (pt) |
| SK (1) | SK2462003A3 (pt) |
| WO (1) | WO2002022613A1 (pt) |
| ZA (1) | ZA200302085B (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012233003B2 (en) * | 2005-12-07 | 2014-12-18 | Basilea Pharmaceutica Ag | Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| DK1965798T3 (da) * | 2005-12-07 | 2011-11-28 | Basilea Pharmaceutica Ag | Nyttige monobactam-antibiotika |
| RU2488394C2 (ru) * | 2007-03-23 | 2013-07-27 | Базилеа Фармацойтика Аг | Комбинированные лекарственные средства для лечения бактериальных инфекций |
| WO2009114921A1 (en) * | 2008-03-17 | 2009-09-24 | Dmitrienko Gary I | INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES |
| LT3412676T (lt) | 2010-08-10 | 2020-07-27 | Melinta Therapeutics, Inc. | Cikliniai borono rūgšties dariniai, jų gamybos būdas ir terapinis panaudojimas |
| WO2013033461A1 (en) | 2011-08-31 | 2013-03-07 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| UY34585A (es) | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
| US9156858B2 (en) | 2012-05-23 | 2015-10-13 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| CN102757405B (zh) * | 2012-07-25 | 2014-04-16 | 山东理工大学 | 含噻二唑的香兰素衍生物、其制备方法及其用途 |
| US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| CA2894891A1 (en) | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| JP6324409B2 (ja) | 2013-01-04 | 2018-05-16 | レンペックス・ファーマシューティカルズ・インコーポレイテッド | ボロン酸誘導体及びその治療的使用 |
| US9101638B2 (en) | 2013-01-04 | 2015-08-11 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| EP3139930A4 (en) | 2014-05-05 | 2018-01-17 | Rempex Pharmaceuticals, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
| LT3140310T (lt) | 2014-05-05 | 2019-11-25 | Rempex Pharmaceuticals Inc | Boronato druskų sintezė ir jų panaudojimas |
| WO2015179308A1 (en) | 2014-05-19 | 2015-11-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| EP3164406A4 (en) | 2014-07-01 | 2018-04-04 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US10662205B2 (en) | 2014-11-18 | 2020-05-26 | Qpex Biopharma, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| EP3233869B1 (en) | 2014-12-19 | 2019-09-25 | Rempex Pharmaceuticals, Inc. | Apparatus and continuous flow process for production of boronic acid derivatives |
| WO2016149393A1 (en) | 2015-03-17 | 2016-09-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| DK3478693T3 (da) | 2016-06-30 | 2021-09-20 | Qpex Biopharma Inc | Boronsyrederivater og terapeutiske anvendelser deraf |
| CN107641119B (zh) * | 2016-07-21 | 2019-11-08 | 中国科学院上海药物研究所 | 单环β-内酰胺-铁载体轭合物及其制备方法和用途 |
| AU2017339587A1 (en) | 2016-12-21 | 2019-07-04 | Aicuris Gmbh & Co. Kg | Combination therapy with amidine substituted ß-lactam compounds and ß-lactamase inhibitors for infections with antibiotic resistant bacterial strains |
| CA3078627A1 (en) | 2017-10-11 | 2019-04-18 | Qpex Biopharma, Inc. | Boronic acid derivatives and synthesis thereof |
| WO2019144969A1 (zh) | 2018-01-29 | 2019-08-01 | 南京明德新药研发股份有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
| CA3097127A1 (en) | 2018-04-20 | 2019-10-24 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| JP7179185B2 (ja) | 2018-12-18 | 2022-11-28 | メッドシャイン ディスカバリー インコーポレイテッド | 医薬の製造おける単環式β－ラクタム化合物の使用 |
| SI25892A (sl) * | 2019-09-05 | 2021-03-31 | Gorenje Gospodinjski Aparati, D.O.O. | Pralni stroj, ki se polni s sprednje strani, z električnim svetlobnim telesom |
| JP2022548067A (ja) | 2019-09-11 | 2022-11-16 | テンノア・セラピューティクス・（スージョウ）・リミテッド | 細菌感染症を治療するためのペナム誘導体 |
| KR20220084398A (ko) | 2019-11-22 | 2022-06-21 | 쑤저우 얼예 파마슈티칼 컴퍼니 리미티드 | 설포닐우레아 고리 치환 모노시클릭 β-락탐계 항생제 |
| CN114828850A (zh) | 2019-12-19 | 2022-07-29 | 南京明德新药研发有限公司 | 化合物在制药中的应用 |
| CN113754651B (zh) * | 2020-06-02 | 2023-04-18 | 中国医学科学院医药生物技术研究所 | 一种β-内酰胺化合物、其用途及其制备方法 |
| CA3229556A1 (en) * | 2021-08-20 | 2023-02-23 | Marvin Miller | Conjugates of monocyclic beta-lactams and siderophore mimetics |
| CN115304594B (zh) | 2022-10-12 | 2023-02-14 | 苏州二叶制药有限公司 | 磺酰脲环取代的化合物的盐型及其晶型 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4632985A (en) | 1985-06-03 | 1986-12-30 | E. R. Squibb & Sons, Inc. | 3-acylamino-2-oxo-1-azetidinesulfonic acids |
| GB8810396D0 (en) | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
| US5112968A (en) * | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
| US5250691A (en) * | 1991-09-09 | 1993-10-05 | E. R. Squibb & Sons, Inc. | Heteroaryl derivatives of monocyclic beta-lactam antibiotics |
| US5888998A (en) * | 1997-04-24 | 1999-03-30 | Synphar Laboratories, Inc. | 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors |
| US5994340A (en) | 1997-08-29 | 1999-11-30 | Synphar Laboratories, Inc. | Azetidinone derivatives as β-lactamase inhibitors |
-
2001
- 2001-09-14 ES ES01980829T patent/ES2244666T3/es not_active Expired - Lifetime
- 2001-09-14 ZA ZA200302085A patent/ZA200302085B/en unknown
- 2001-09-14 KR KR1020037003718A patent/KR100854810B1/ko not_active IP Right Cessation
- 2001-09-14 IL IL15459301A patent/IL154593A0/xx active IP Right Grant
- 2001-09-14 EP EP01980829A patent/EP1322648B1/en not_active Expired - Lifetime
- 2001-09-14 PL PL360537A patent/PL218196B1/pl unknown
- 2001-09-14 HU HU0301025A patent/HUP0301025A3/hu unknown
- 2001-09-14 DE DE60111757T patent/DE60111757T2/de not_active Expired - Lifetime
- 2001-09-14 DK DK01980829T patent/DK1322648T3/da active
- 2001-09-14 CN CNB018157319A patent/CN1189469C/zh not_active Expired - Fee Related
- 2001-09-14 WO PCT/IB2001/002115 patent/WO2002022613A1/en active IP Right Grant
- 2001-09-14 CZ CZ2003-606A patent/CZ304586B6/cs not_active IP Right Cessation
- 2001-09-14 CA CA2422375A patent/CA2422375C/en not_active Expired - Fee Related
- 2001-09-14 SK SK246-2003A patent/SK2462003A3/sk unknown
- 2001-09-14 PT PT01980829T patent/PT1322648E/pt unknown
- 2001-09-14 AU AU1261402A patent/AU1261402A/xx active Pending
- 2001-09-14 BR BR0113861-8A patent/BR0113861A/pt active Search and Examination
- 2001-09-14 US US10/363,222 patent/US6916803B2/en not_active Expired - Fee Related
- 2001-09-14 NZ NZ524292A patent/NZ524292A/en unknown
- 2001-09-14 AU AU2002212614A patent/AU2002212614B2/en not_active Ceased
- 2001-09-14 AT AT01980829T patent/ATE298750T1/de active
- 2001-09-14 JP JP2002526866A patent/JP2004509122A/ja active Pending
-
2003
- 2003-02-24 IL IL154593A patent/IL154593A/en not_active IP Right Cessation
- 2003-03-13 NO NO20031162A patent/NO324946B1/no not_active IP Right Cessation
- 2003-09-03 HK HK03106287A patent/HK1054377A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL154593A0 (en) | 3-(heteroaryl acetamido)-2-oxoazetidine-1-sulfonic acid derivatives as antibacterial agents | |
| EA200501098A1 (ru) | Антибактериальные агенты | |
| EA200100623A1 (ru) | Кетолидные антибиотики | |
| PA8486401A1 (es) | Antibioticos cetolidos carbamato y carbazato | |
| EA200100396A1 (ru) | Новые макролидные антибиотики | |
| EA200400701A1 (ru) | 13-членные азалиды и их применение в качестве антибиотических агентов | |
| TR200400630T4 (tr) | Ketolit antibiyotikleri | |
| EA200600374A1 (ru) | Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью | |
| MXPA05009688A (es) | Derivados de naftiridina como agentes antibacterianos. | |
| ES2161344T3 (es) | Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares. | |
| SI0801655T1 (en) | Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics | |
| NO20010140L (no) | Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse | |
| PT1289998E (pt) | Novo processo para a preparacao de derivados de vinil-pirrolidinona cefalosporina | |
| PT1167376E (pt) | Antibioticos macrolidos | |
| CA2332686A1 (en) | Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates | |
| EA200201167A1 (ru) | Производные гигромицина а для лечения бактериальных и протозойных инфекций | |
| DE60326710D1 (de) | Trizyklische antibakterielle makrolidderivate | |
| PE64099A1 (es) | Antibiotico derivado de cefalosporinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| FF | Patent granted |